BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30798632)

  • 21. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live offspring from vitrified blastocysts derived from fresh and cryopreserved ovarian tissue grafts of adult mice.
    Wang X; Catt S; Pangestu M; Temple-Smith P
    Reproduction; 2009 Sep; 138(3):527-35. PubMed ID: 19556437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current challenges to efficient immature oocyte cryopreservation.
    Brambillasca F; Guglielmo MC; Coticchio G; Mignini Renzini M; Dal Canto M; Fadini R
    J Assist Reprod Genet; 2013 Dec; 30(12):1531-9. PubMed ID: 24114631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
    Huang JY; Tulandi T; Holzer H; Tan SL; Chian RC
    Fertil Steril; 2008 Mar; 89(3):567-72. PubMed ID: 17543957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
    Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo Retrieval of Mature Oocytes for Fertility Preservation in a Patient with Bilateral Borderline Ovarian Tumor.
    de Carvalho BR; Cintra GF; Franceschi TM; Cabral ÍO; Resende LSA; Gumz BP; Pinto TDA
    Rev Bras Ginecol Obstet; 2021 Mar; 43(3):225-231. PubMed ID: 33465787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
    Walls M; Junk S; Ryan JP; Hart R
    Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Random-start ovarian stimulation in patients with cancer.
    Cakmak H; Rosen MP
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro oocyte maturation for female fertility preservation].
    Sonigo C; Grynberg M
    Gynecol Obstet Fertil; 2014 Sep; 42(9):657-60. PubMed ID: 25153445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
    Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
    Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
    Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
    J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
    Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
    Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification.
    Shalom-Paz E; Almog B; Shehata F; Huang J; Holzer H; Chian RC; Son WY; Tan SL
    Reprod Biomed Online; 2010 Oct; 21(4):566-71. PubMed ID: 20822957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
    Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
    J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live birth following vitrification of in vitro matured oocytes derived from sibling smaller follicles at follicle selection phase in the context of in vitro fertilization.
    Chen H; Lv JQ; Ge HS; Wu XM; Xi HT; Chi HH; Zhu CF; Huang JY
    Gynecol Endocrinol; 2014 Sep; 30(9):624-6. PubMed ID: 24734870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.